These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 23382133)

  • 1. Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome.
    Aspinwall LG; Taber JM; Leaf SL; Kohlmann W; Leachman SA
    Psychooncology; 2013 Feb; 22(2):276-89. PubMed ID: 23382133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderators of cancer-related distress and worry after a pancreatic cancer genetic counseling and screening intervention.
    Hart SL; Torbit LA; Crangle CJ; Esplen MJ; Holter S; Semotiuk K; Borgida A; Ardiles P; Rothenmund H; Gallinger S
    Psychooncology; 2012 Dec; 21(12):1324-30. PubMed ID: 21774034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary melanoma and predictive genetic testing: why not?
    Riedijk SR; de Snoo FA; van Dijk S; Bergman W; van Haeringen A; Silberg S; van Elderen TM; Tibben A
    Psychooncology; 2005 Sep; 14(9):738-45. PubMed ID: 15744786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDKN2A/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families.
    Aspinwall LG; Leaf SL; Dola ER; Kohlmann W; Leachman SA
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1510-9. PubMed ID: 18559569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic testing in familial melanoma: uptake and implications.
    de Snoo FA; Riedijk SR; van Mil AM; Bergman W; ter Huurne JA; Timman R; Bertina W; Gruis NA; Vasen HF; van Haeringen A; Breuning MH; Tibben A
    Psychooncology; 2008 Aug; 17(8):790-6. PubMed ID: 18613292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.
    Aspinwall LG; Stump TK; Taber JM; Drummond DM; Kohlmann W; Champine M; Leachman SA
    Transl Behav Med; 2018 Jan; 8(1):29-43. PubMed ID: 29385581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priority of Risk (But Not Perceived Magnitude of Risk) Predicts Improved Sun-Protection Behavior Following Genetic Counseling for Familial Melanoma.
    Taber JM; Aspinwall LG; Drummond DM; Stump TK; Kohlmann W; Champine M; Cassidy P; Leachman SA
    Ann Behav Med; 2021 Feb; 55(1):24-40. PubMed ID: 32415830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family members' perceptions of genetic testing for malignant melanoma--a prospective interview study.
    Bergenmar M; Hansson J; Brandberg Y
    Eur J Oncol Nurs; 2009 Apr; 13(2):74-80. PubMed ID: 19179113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic cancer and melanoma related perceptions and behaviors following disclosure of CDKN2A variant status as a research result.
    Leof ER; Zhu X; Rabe KG; McCormick JB; Petersen GM; Radecki Breitkopf C
    Genet Med; 2019 Nov; 21(11):2468-2477. PubMed ID: 30992552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.
    Gritz ER; Peterson SK; Vernon SW; Marani SK; Baile WF; Watts BG; Amos CI; Frazier ML; Lynch PM
    J Clin Oncol; 2005 Mar; 23(9):1902-10. PubMed ID: 15774782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
    van Oostrom I; Meijers-Heijboer H; Lodder LN; Duivenvoorden HJ; van Gool AR; Seynaeve C; van der Meer CA; Klijn JG; van Geel BN; Burger CW; Wladimiroff JW; Tibben A
    J Clin Oncol; 2003 Oct; 21(20):3867-74. PubMed ID: 14551306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nature and structure of psychological distress in people at high risk for melanoma: a factor analytic study.
    Kasparian NA; Sansom-Daly U; McDonald RP; Meiser B; Butow PN; Mann GJ
    Psychooncology; 2012 Aug; 21(8):845-56. PubMed ID: 21612004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Test Reporting and Counseling for Melanoma Risk in Minors May Improve Sun Protection Without Inducing Distress.
    Stump TK; Aspinwall LG; Kohlmann W; Champine M; Hauglid J; Wu YP; Scott E; Cassidy P; Leachman SA
    J Genet Couns; 2018 Aug; 27(4):955-967. PubMed ID: 29349527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of melanoma genetic test reporting on perceived control over melanoma prevention.
    Aspinwall LG; Stump TK; Taber JM; Kohlmann W; Leaf SL; Leachman SA
    J Behav Med; 2015 Oct; 38(5):754-65. PubMed ID: 25822116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological Impact of Learning CDKN2A Variant Status as a Genetic Research Result.
    Zhu X; Leof ER; Rabe KG; McCormick JB; Petersen GM; Radecki Breitkopf C
    Public Health Genomics; 2018; 21(3-4):154-163. PubMed ID: 30999302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of photoprotection following CDKN2A/p16 genetic test reporting and counseling.
    Aspinwall LG; Leaf SL; Kohlmann W; Dola ER; Leachman SA
    J Am Acad Dermatol; 2009 May; 60(5):745-57. PubMed ID: 19278751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma.
    Collins V; Meiser B; Gaff C; St John DJ; Halliday J
    Cancer; 2005 Jul; 104(2):273-81. PubMed ID: 15948171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning.
    Maheu C; Vodermaier A; Rothenmund H; Gallinger S; Ardiles P; Semotiuk K; Holter S; Thayalan S; Esplen MJ
    Fam Cancer; 2010 Dec; 9(4):617-24. PubMed ID: 20623197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.
    Begg CB; Orlow I; Hummer AJ; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Mitra N; Busam K; From L; Berwick M;
    J Natl Cancer Inst; 2005 Oct; 97(20):1507-15. PubMed ID: 16234564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of psychological distress among individuals with a strong family history of malignant melanoma.
    Kasparian NA; Meiser B; Butow PN; Simpson JM; Mann GJ
    Clin Genet; 2008 Feb; 73(2):121-31. PubMed ID: 18177469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.